Peptide Stacking Guide
Explore how peptides interact at the molecular level in published research. All information is for research purposes only.
Synergy Mechanism
BPC-157 Role
- • Growth factor modulation (VEGF, EGF)
- • Nitric oxide pathway activation
- • GI tract signalling research
- • Brain-gut axis investigation
TB-500 Role
- • Systemic distribution via circulation
- • Actin-binding and cell migration
- • Anti-fibrotic signalling pathways
- • Follicle-related research
Areas of Published Research
Musculoskeletal Models
Tendon, ligament, and connective tissue studies in test subjects
Tissue Modelling
Wound closure and tissue remodelling research
GI Tract Research
Gastrointestinal signalling pathway studies
Published Literature
Refer to peer-reviewed publications for specific research parameters used in published studies. This combination has been referenced in multiple preclinical research papers.
Synergy Mechanism
CJC-1295 NO DAC Role
- • GHRH (Growth Hormone Releasing Hormone) analog
- • NO DAC = preserves natural pulsatile GH release pattern
- • Amplifies endogenous GH pulse signalling
- • Mimics hypothalamic GHRH signalling
- • Synergistic with ghrelin pathway
Ipamorelin Role
- • Ghrelin receptor (GHS-R) agonist
- • Pulsatile GH signalling
- • Direct pituitary stimulation
- • Selective receptor binding (no cortisol/prolactin elevation observed)
Areas of Published Research
GH Axis Signalling
Somatotropic axis modulation studies
IGF-1 Pathways
IGF-1 elevation and downstream signalling
Skeletal Research
Bone mineral density studies in test subjects
Metabolic Pathways
Metabolic signalling and substrate utilisation
Published Literature
Refer to peer-reviewed publications for specific research parameters used in published studies. This dual-pathway combination is well-documented in GH axis research.
Synergy Mechanism
PT-141 (Bremelanotide) Role
- • Melanocortin receptor (MC3R/MC4R) activation
- • Central nervous system pathway signalling
- • Non-vascular mechanism (unlike PDE5 inhibitors)
- • Selective MC receptor binding profile
Melanotan II Role
- • Broad-spectrum melanocortin agonist (MC1R-MC5R)
- • Melanogenesis pathway activation
- • Appetite-related signalling pathways
- • Synergistic melanocortin receptor activation with PT-141
Areas of Published Research
MC Receptor Signalling
Melanocortin receptor activation and downstream effects in test subjects
Pigmentation Pathways
Melanogenesis and MC1R signalling research
CNS Pathway Studies
Central nervous system melanocortin signalling
Published Literature
Refer to peer-reviewed publications for specific research parameters. Melanocortin receptor research is an active area of investigation in multiple academic institutions.
Synergy Mechanism
GHK-Cu (Copper Peptide) Role
- • Collagen and elastin synthesis signalling
- • Antioxidant and cellular signalling effects
- • Tissue remodeling pathways
- • Copper ion delivery for enzymatic functions
BPC-157 Role
- • Angiogenesis signalling (blood vessel formation)
- • Growth factor modulation (VEGF, EGF, FGF)
- • Tissue remodelling pathways
- • Systemic signalling support
Areas of Published Research
Collagen Synthesis
Collagen density and extracellular matrix studies in test subjects
Follicle Research
Hair follicle signalling and growth factor studies
Tissue Remodelling
Wound closure and tissue architecture studies
Oxidative Stress
Cellular senescence and antioxidant pathway research
Keratin Pathways
Keratin production and structural protein studies
Barrier Function
Dermal barrier and microbiome interaction research
Optional Research Additions
+ CJC-1295 NO DAC/Ipamorelin: GH axis signalling supports collagen synthesis pathways
+ TB-500: Systemic tissue signalling, follicle-related research
+ NAD+: Cellular energy, DNA repair, and mitochondrial function research
Published Literature
Refer to peer-reviewed publications for specific research parameters. GHK-Cu has been extensively studied in dermal research contexts.
Component Roles
BPC-157
GI tract signalling, neurotrophic pathways, vascular research via growth factor modulation
TB-500
Systemic distribution, cell migration research, anti-fibrotic signalling through actin-binding
GHK-Cu
Collagen/elastin synthesis signalling, antioxidant research, tissue remodeling via copper ion delivery and TGF-beta pathways
KPV (Lys-Pro-Val)
Regulatory peptide research, GI signalling, melanocyte-stimulating hormone derivative studies
Multi-Pathway Synergy
Cellular Signalling Coverage
BPC-157 (growth factors) + TB-500 (systemic) + GHK-Cu (antioxidant) + KPV (regulatory peptide) = multiple signalling pathway coverage in research models
Tissue Architecture
GHK-Cu collagen synthesis + TB-500 anti-fibrotic signalling + BPC-157 remodeling pathways studied in tissue models
Gut-Systemic Connection
BPC-157 + KPV GI tract signalling while TB-500 + GHK-Cu provide systemic pathway coverage
Areas of Published Research
Multi-Tissue Models
Complex tissue signalling requiring multiple pathway coverage
Inflammatory Pathways
Inflammatory signalling cascade research in test subjects
Longevity Research
Cellular senescence and tissue regeneration studies
Published Literature
Refer to peer-reviewed publications for specific research parameters used in published studies. Each component has independent published research supporting its molecular mechanisms.
Reconstitution
Use bacteriostatic water for multi-use vials. Most peptides are stable when refrigerated for 2-4 weeks after reconstitution.
Storage
Lyophilized peptides: Store at -20°C or below. Reconstituted peptides: Refrigerate at 2-8°C. Protect from light and avoid repeated freeze-thaw cycles.
Compatibility
Peptides in the same stack can typically be reconstituted together. Check our Interaction Matrix for specific compatibility information.
Research Documentation
Maintain detailed laboratory logs of all research parameters, observations, and results. Track relevant biomarkers where applicable.
Research Use Only Disclaimer
All information provided is for research and educational purposes only. These products are not approved for human consumption and are sold strictly as research chemicals for laboratory use. Peak Peptides Australia does not provide medical advice, therapeutic recommendations, or guidance on human administration. Refer to published peer-reviewed literature for specific research parameters. All products are sold in accordance with Australian regulations governing research chemicals.